Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Learn
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Japara Healthcare Announces Results for H1 FY2017

27 Feb 2017  |  09:28:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: FY17 Half Year Media Release

Japara Healthcare announced its results for the half year ended 31 December 2016. The Company reported total revenue of $178.5m, up 14.5% on H1 FY16. Average underlying occupancy remained strong at 94.4%. EBITDA increased to $29.1m, up 3.6% on H1 FY16. The Company continued its good record of strong cash generation, delivering net operating cash flows of $37.4m plus net cash inflows from RADs of $29.0m. It has slightly revised its FY17 outlook, with EBITDA expected to grow at 7% - 10% on FY16. The Board has determined to pay a fully franked interim dividend of 5.5 cps on 28 April 2017. The Company's DRP will operate in respect of the interim dividend.

Please click here for full details

See more ASX300 News Announcements